News
- Elanco Announces Agreement to Acquire Kindred BiosciencesJune 16, 2021 6:30 AM EDT
- Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by ParvovirusJune 2, 2021 8:31 AM EDT
- Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XIMay 25, 2021 8:42 AM EDT
Events
- Tuesday, June 8, 2021 from 1:30 PM to 1:55 PM EDT
- Wednesday, June 2, 2021 from 11:00 AM to 11:25 AM EDT
- Tuesday, May 11, 2021 4:30 PM EDT
|
KindredBio proudly supports
Rabies Free Africa
Press Release
Dr.Richard Chin , Chief Executive Officer, will present via webcast at 10.50am ET and be available for virtual one-on-one meetings. During this time, investors will have the opportunity to discuss recent developments, study results from key therapeutic programs in development, and upcoming milestones.
An archived version of the above webcast will be available for 30 days on the KindredBio website.
About Kindred Biosciences
For more information, visit: www.kindredbio.com
Contact
Katja Buhrer
katja.buhrer@kindredbio.com
(917) 969-3438
SOURCEKindred Biosciences, Inc.